These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30347132)

  • 1. Recommendation for terminology: Nodules without arterial phase hyperenhancement and with hepatobiliary phase hypointensity in chronic liver disease.
    Motosugi U; Murakami T; Lee JM; Fowler KJ; Heiken JP; Sirlin CB;
    J Magn Reson Imaging; 2018 Nov; 48(5):1169-1171. PubMed ID: 30347132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
    Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
    World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatobiliary phase hypointensity predicts progression to hepatocellular carcinoma for intermediate-high risk observations, but not time to progression.
    Vernuccio F; Cannella R; Choudhury KR; Meyer M; Furlan A; Marin D
    Eur J Radiol; 2020 Jul; 128():109018. PubMed ID: 32388318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
    PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
    Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM
    J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent.
    Kim SY; Wu EH; Park SH; Wang ZJ; Hope TA; Yee J; Zhao LQ; Chang WC; Yeh BM
    Abdom Radiol (NY); 2016 Aug; 41(8):1522-31. PubMed ID: 26971341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
    Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
    AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfalls in liver MRI: Technical approach to avoiding misdiagnosis and improving image quality.
    Yacoub JH; Elsayes KM; Fowler KJ; Hecht EM; Mitchell DG; Santillan C; Szklaruk J
    J Magn Reson Imaging; 2019 Jan; 49(1):41-58. PubMed ID: 30295343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI-RADS).
    Chernyak V; Fowler KJ; Heiken JP; Sirlin CB
    J Magn Reson Imaging; 2019 May; 49(5):1236-1252. PubMed ID: 30609194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.
    Agnello F; Dioguardi Burgio M; Picone D; Vernuccio F; Cabibbo G; Giannitrapani L; Taibbi A; Agrusa A; Bartolotta TV; Galia M; Lagalla R; Midiri M; Brancatelli G
    World J Gastroenterol; 2016 Jan; 22(1):103-11. PubMed ID: 26755863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma.
    Hwang JA; Kang TW; Kim YK; Kim SH; Paik YH; Ha SY; Kim S
    Eur J Radiol; 2017 Oct; 95():362-369. PubMed ID: 28987693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging features related with prognosis of hepatocellular carcinoma.
    An C; Kim MJ
    Abdom Radiol (NY); 2019 Feb; 44(2):509-516. PubMed ID: 30171295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese consensus on the clinical application of hepatobiliary magnetic resonance imaging contrast agent: Gadoxetic acid disodium.
    Rao SX; Wang J; Wang J; Jiang XQ; Long LL; Li ZP; Li ZL; Shen W; Zhao XM; Hu DY; Zhang HM; Zhang L; Huan Y; Liang CH; Song B; Zeng MS
    J Dig Dis; 2019 Feb; 20(2):54-61. PubMed ID: 30693659
    [No Abstract]   [Full Text] [Related]  

  • 18. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
    Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma with central scar on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging.
    Han SB; Kim YK; Min JH; Ha SY; Jeong WK; Lee WJ
    Acta Radiol; 2018 Apr; 59(4):393-401. PubMed ID: 28760004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers.
    Bartolozzi C; Battaglia V; Bargellini I; Bozzi E; Campani D; Pollina LE; Filipponi F
    Abdom Imaging; 2013 Apr; 38(2):290-6. PubMed ID: 23053453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.